Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics

Author： Widmer Nicolas  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.11, 2010-11, pp. : 741-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2009 H1N1 Pandemic Influenza: Let's Get Involved!

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 4, 2009-12 ,pp. : 259-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oseltamivir, zanamivir leading the charge against influenza H5N1

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Sensitivity of H5N1 influenza viruses to oseltamivir: an update

By Rameix-Welti Marie-Anne   van der Werf Sylvie   Naffakh Nadia  

Future Virology, Vol. 3, Iss. 2, 2008-03 ,pp. : 157-165

Future Medicine

Access to resources Recommend Favorite

Hospital Experience of an Avian Influenza A (H5N1) Outbreak in Turkey

By Sahin HA   Deveci A  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1501-1507

Field House Publishing

Access to resources Recommend Favorite

What did the 2009 H1N1 pandemic teach us about influenza surveillance systems?

By Stoto Michael A  

Future Virology, Vol. 8, Iss. 9, 2013-09 ,pp. : 829-832

Future Medicine

Access to resources Recommend Favorite